Mapatumumab
Mapatumumab Basic information
- Product Name:
- Mapatumumab
- Synonyms:
-
- Mapatumumab
- Research Grade Mapatumumab (DHA05901)
- Research Grade Mapatumumab
- Mapatumumab (anti-TNFRSF10A)
- CAS:
- 658052-09-6
- MW:
- 0
- Mol File:
- Mol File
More
Less
Mapatumumab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Mapatumumab Usage And Synthesis
Uses
Treatment of cancer.
in vivo
Mapatumumab (10 mg/kg; i.p. for three times) controls tumor growth when combined with irradiation[3].
| Animal Model: | Colo205-xenograft–bearing NMRI (nu/nu) nude mice[3] |
| Dosage: | 10 mg/kg |
| Administration: | Intraperitoneal injection; 10 mg/kg; on days 1, 4, and 8 |
| Result: | Showed no significant differences when used alone, but when combined with irradiation (5×3 Gy, d1–5) showed a pronounced tumor regrowth-delay. |
MapatumumabSupplier
Wuhan Chemstan Biotechnology Co., Ltd. Gold
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
NCE Biomedical Co.,Ltd.
- Tel
- 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
LETOPHARM LIMITED
- Tel
- +86-21-5821 5861
- sales@letopharm.com
SPIRO PHARMA
- Tel
- eric_feng1954@126.com
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com